Published in J Med Chem on November 07, 1997
BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist. Br J Pharmacol (2000) 1.08
NPY receptors as potential targets for anti-obesity drug development. Br J Pharmacol (2011) 0.96
Neuropeptide Y receptors: how to get subtype selectivity. Front Endocrinol (Lausanne) (2013) 0.94
Review of the neuroanatomic landscape implicated in glucose sensing and regulation of nutrient signaling: immunophenotypic localization of diabetes gene Tcf7l2 in the developing murine brain. J Chem Neuroanat (2012) 0.75
Proposed mechanism of force generation in striated muscle. Nature (1971) 21.45
Single myosin molecule mechanics: piconewton forces and nanometre steps. Nature (1994) 13.73
Tension responses to sudden length change in stimulated frog muscle fibres near slack length. J Physiol (1977) 12.53
Elasticity and unfolding of single molecules of the giant muscle protein titin. Nature (1997) 7.61
The relation between stiffness and filament overlap in stimulated frog muscle fibres. J Physiol (1981) 5.48
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem (2001) 4.45
Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol Pharmacol (1986) 4.15
A rapid filtration assay for soluble receptors using polyethylenimine-treated filters. Anal Biochem (1983) 3.63
Cooperative hernia study. Pain in the postrepair patient. Ann Surg (1996) 3.57
Single-molecule biomechanics with optical methods. Science (1999) 3.35
Control of sarcomere length in skinned muscle fibres of Rana temporaria during mechanical transients. J Physiol (1984) 3.21
Adenosine receptors in brain membranes: binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine. Proc Natl Acad Sci U S A (1980) 3.20
A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Arch Gen Psychiatry (1997) 3.11
The dependence of force and shortening velocity on substrate concentration in skinned muscle fibres from Rana temporaria. J Physiol (1984) 2.97
Changes in the X-ray reflections from contracting muscle during rapid mechanical transients and their structural implications. J Mol Biol (1983) 2.69
Adenosine receptors and behavioral actions of methylxanthines. Proc Natl Acad Sci U S A (1981) 2.66
Adenosine receptors in the central nervous system: relationship to the central actions of methylxanthines. Life Sci (1981) 2.58
Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder. Arch Gen Psychiatry (2000) 2.57
Tension transients during steady shortening of frog muscle fibres. J Physiol (1985) 2.54
Changes in the lateral filament spacing of skinned muscle fibres when cross-bridges attach. J Mol Biol (1984) 2.52
Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes. Naunyn Schmiedebergs Arch Pharmacol (1987) 2.36
Synthesis and evaluation of a series of novel 2-[(4-chlorophenoxy)methyl]benzimidazoles as selective neuropeptide Y Y1 receptor antagonists. J Med Chem (1998) 2.23
Tension transients during the rise of tetanic tension in frog muscle fibres. J Physiol (1986) 2.18
Rapid 'give' and the tension 'shoulder' in the relaxation of frog muscle fibres. J Physiol (1970) 2.07
A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology (2006) 2.05
Species differences in affinities of non-peptide antagonists for substance P receptors. Eur J Pharmacol (1991) 1.95
Active and rigor muscle stiffness [proceedings]. J Physiol (1977) 1.90
Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists. Can J Physiol Pharmacol (1980) 1.88
Millisecond time-resolved changes in x-ray reflections from contracting muscle during rapid mechanical transients, recorded using synchrotron radiation. Proc Natl Acad Sci U S A (1981) 1.84
New observations on the normal auditory startle reflex in man. Brain (1991) 1.80
Sporadic Creutzfeldt-Jakob disease in a 16-year-old in the UK. Lancet (1995) 1.78
The stiffness of frog skinned muscle fibres at altered lateral filament spacing. J Physiol (1986) 1.76
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol (2010) 1.74
Proceedings: Mechanism of early tension recovery after a quick release in tetanized muscle fibres. J Physiol (1974) 1.71
Electrocardiographic prediction of abnormal genotype in congenital long QT syndrome: experience in 101 related family members. J Cardiovasc Electrophysiol (2001) 1.71
Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J Biol Chem (2000) 1.69
Adenosine receptor binding: structure-activity analysis generates extremely potent xanthine antagonists. Proc Natl Acad Sci U S A (1983) 1.68
The clinical picture of major depression in children and adolescents. Arch Gen Psychiatry (1987) 1.68
Mechanical properties of the cross-bridges of frog striated muscle. J Physiol (1971) 1.64
DIABEDS: a randomized trial of the effects of physician and/or patient education on diabetes patient outcomes. J Chronic Dis (1987) 1.64
A quick phase in the series-elastic component of striated muscle, demonstrated in isolated fibres from the frog. J Physiol (1970) 1.61
Adenosine antagonism by purines, pteridines and benzopteridines in human fibroblasts. Biochem Pharmacol (1981) 1.59
Models of motor-assisted transport of intracellular particles. Biophys J (2001) 1.55
Identification of the first trans-(3R,4R)- dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity. J Med Chem (2001) 1.54
Ethyl-substituted erythromycin derivatives produced by directed metabolic engineering. Proc Natl Acad Sci U S A (1998) 1.50
Subclasses of angiotensin II binding sites and their functional significance. Mol Pharmacol (1990) 1.48
PD 115,199: an antagonist ligand for adenosine A2 receptors. Naunyn Schmiedebergs Arch Pharmacol (1987) 1.48
In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation (2001) 1.46
Improving the design of muscle relaxant studies. Stabilization period and tetanic recruitment. Anesthesiology (1997) 1.45
Prevalence and predictors of pervasive noncompliance with medical treatment among youths with insulin-dependent diabetes mellitus. J Am Acad Child Adolesc Psychiatry (1992) 1.45
Is locked seclusion necessary for children under the age of 14? Am J Psychiatry (1990) 1.45
Neurobiology of depression: an integrated view of key findings. Int J Clin Pract (2007) 1.44
Reaction mechanism of the magnesium ion-dependent adenosine triphosphatase of frog muscle myosin and subfragment 1. Biochem J (1978) 1.44
British Prisoners Released by Napoleon at Jenner's Request: (Section of the History of Medicine). Proc R Soc Med (1939) 1.43
Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat. J Neurosci (1995) 1.42
Further Notes on Thomas Dover. Proc R Soc Med (1913) 1.40
Secondary prevention of fragility fractures by orthopaedic teams in the UK: a national survey. Int J Clin Pract (2008) 1.39
ADVANTAGES TO THE DIABETIC OF A DIET RICH IN CARBOHYDRATES. Br Med J (1930) 1.39
EZH2 Y641 mutations in follicular lymphoma. Leukemia (2011) 1.37
A capacitance-gauge tension transducer. J Physiol (1968) 1.36
Hidden-Markov methods for the analysis of single-molecule actomyosin displacement data: the variance-Hidden-Markov method. Biophys J (2001) 1.36
The hyperekplexias and their relationship to the normal startle reflex. Brain (1991) 1.36
Clinical validation of the "in silico" prediction of immunogenicity of a human recombinant therapeutic protein. Clin Immunol (2007) 1.33
Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosis. Nephrol Dial Transplant (2000) 1.33
beta-Amyloid peptide in vitro toxicity: lot-to-lot variability. Neurobiol Aging (1993) 1.31
Identification of a high-affinity binding site involved in the transport of endocannabinoids. Proc Natl Acad Sci U S A (2005) 1.30
D-1 dopamine receptors in the rat brain: a quantitative autoradiographic analysis. J Neurosci (1986) 1.27
The instantaneous elasticity of frog skeletal muscle fibres [proceedings]. J Physiol (1976) 1.26
A demonstration of the intrinsic importance of stabilizing hydrophobic binding and non-covalent van der Waals contacts dominant in the non-covalent CC-1065/B-DNA binding. Chem Biol Interact (1990) 1.24
In situ and infiltrating ductal carcinoma arising in a breast hamartoma. AJR Am J Roentgenol (2000) 1.23
Assessment and reporting of the clinical immunogenicity of therapeutic proteins and peptides-harmonized terminology and tactical recommendations. AAPS J (2014) 1.22
Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. Eur J Pharmacol (1999) 1.21
Extra-pulmonary manifestations of sarcoidosis. Clin Radiol (2011) 1.20
Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav Brain Res (1999) 1.19
New structural concepts for narcotic antagonists defined in a 4-phenylpiperidine series. Nature (1978) 1.18
Comparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice. Psychopharmacology (Berl) (1989) 1.17
Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients. J Am Coll Surg (2000) 1.15
Adenosine receptor activation by adenine nucleotides requires conversion of the nucleotides to adenosine. Naunyn Schmiedebergs Arch Pharmacol (1980) 1.15
Functional MR of frontal lobe activation: comparison with Wada language results. AJNR Am J Neuroradiol (1998) 1.14
Identification of an opioid kappa receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine. J Med Chem (1998) 1.14
Psychological functioning among mothers of children with insulin-dependent diabetes mellitus: a longitudinal study. J Consult Clin Psychol (1990) 1.13
Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J Biol Chem (1995) 1.12
A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. Eur J Neurol (2009) 1.12
Identification of a DNA-binding protein of human herpesvirus 6, a putative DNA polymerase stimulatory factor. J Gen Virol (1993) 1.12
Magnetic stimuli applied over motor and visual cortex: influence of coil position and field polarity on motor responses, phosphenes, and eye movements. Electroencephalogr Clin Neurophysiol Suppl (1991) 1.11
Selectivity and specificity of new, non-peptide, quinuclidine antagonists of substance P. Biochem Biophys Res Commun (1991) 1.10
Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats. Neuropharmacology (2002) 1.10